Greece’s Financial Crisis and Devastated Healthcare System - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Greece’s Financial Crisis and Devastated Healthcare System
Greece’s economic crisis has battered the country’s healthcare system, resulting in medicine shortages, market withdrawals and falling profits for the pharma industry.


Pharmaceutical Technology Europe


References

1. A. Kentikelenis, "Health effects of financial crisis: omens of a Greek tragedy" (Lancet website, 2011) http://ww.thelancet.com/, accessed 27 Feb., 2012.

2. A. Carassava, "Euro crisis: Why Greece is the sick man of Europe" (BBC News website, 2011). http://www.bbc.co.uk/, accessed 27 Feb., 2012.

3. Healthcare Economist, "Health Care Around the World: Greece" (Healthcare Economist website, 2008). http://healthcare-economist.com/, accessed 27 Feb., 2012.

4. E. Karamanoli, "Greece's financial crisis dries up drug supply" (Lancet website 2012). http://www.thelancet.com/, accessed 27 Feb., 2012.

5. N. Kresge, "Greek Crisis Dries Up Drug Supply as Even Aspirin Can't Be Found" (Bloomber GusinessWeek website, 2012). http://www.businessweek.com/, accessed 27 Feb., 2012.

6. Pharmaceutical-Technology, "Greece confirms state pharmaceutical spend" (Pharmaceutical-Technology website, 2012). http://www.pharmaceutical-technology.com/, accessed 27 Feb., 2012.

7. Pharmalot, "Novo Nordisk Pulls Insulin From Greece Over Money" (Pharmalot website, 2010). http://www.pharmalot.com/, accessed 27 Feb., 2012.

8. L. Taylor, "Danish drugmakers' "no" to Greek price cuts" (Pharma Times, 2010). http://www.pharmatimes.com/, accessed 27 Feb., 2012.

9. A. Roy, "America's Future? Greece Defaults on Cancer Treatments in State-Owned Hospitals" (Forbes, 2011). http://www.forbes.com/, accessed 27 Feb., 2012.

10. C. Papachlimintzos, "Medicine in Greece is cheap" (Athens News, 2011). http://www.athensnews.gr, accessed 27 Feb., 2012.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Source: Pharmaceutical Technology Europe,
Click here